Skip to main content
OpenTrials

Clinical trial condition

Synucleinopathies

Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.

3,496 public trials 645 recruiting studies
Refine in advanced search Browse all conditions

Synucleinopathies trial results

Completed

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

NCT00143026

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Royal Adelaide Hospital Adelaide, Australia
  • Watkins Medical Center Brisbane, Australia
  • Central Coast Neuroscience Research Gosford, Australia
  • Heidelberg Repatriation Hospital Melbourne, Australia
View all 18 locations
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease

NCT02224664

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • Orange Coast Memorial Medical Center Fountain Valley, California, United States
  • The Parkinson's and Movement Disorder Institute Fountain Valley, California, United States
  • Collaborative Neuroscience Network, LLC Long Beach, California, United States
  • Rocky Mountain Movement Disorders Center Englewood, Colorado, United States
View all 17 locations
View Trial Details
Completed

An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease

NCT00632736

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Fountain Valley, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Englewood, Colorado, United States
View all 75 locations
View Trial Details
Completed

Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa

NCT00381472

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Northridge, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Englewood, Colorado, United States
View all 76 locations
View Trial Details

Related conditions